Oslo, 22 August 2025: Damgård Invest AS, a company controlled by Andreas Enger, CEO of Höegh Autoliners ASA and primary insider, has today sold 408 719 shares in Höegh Autoliners ASA at an average ...

HAV Group ASA invites investors, analysts and journalists to a webcast presentation of its second quarter 2025 financial results. Time and d ...

Sandnes, Norway, 21 August 2025 – Horisont Energi AS (“Horisont Energi” or the “Company”) announces its unaudited results for the first half of 2025 and the Board of Directors’ decision to plan for an ...

across the world. The Company operates around 40 RoRo vessels in global trade systems and makes more than 2 000 port calls each year. Our purpose is to To subscribe to Press releases from this issuer, ...

Reference is made to the stock exchange announcement of 25 June 2025 regarding the board of directors of Sparebanken Norge's decision on a program for employee purchase of equity capital certificates ...

Elmera Group leverte en justert net revenue på NOK 370m i andre kvartal 2025, en nedgang fra NOK 389m i andre kvartal 2024. Justert driftsresultat (EBIT adj.) i kvartalet endte på NOK 93m, ned fra NOK ...

Home Equities - Stocks - Shares Company Press Releases Outstanding Shares and Voting Rights Monthly Statement At July 31st, 2025 ...

23, Place des Carmes-Déchaux - 63000 CLERMONT-FERRAND Information about securities repurchasing program Regulated information Issuer social denomination: Michelin – LEI 549300SOSI58J6VIW052 Types of ...

Operational & Corporate Update for the period ended 31 March 2025 More information:Access the news on Oslo Bors NewsWeb site ...

2025, at 09:00 (CET). Cyviz AS will release its Q2 2025 report and presentation on Thursday, 21st of August 2025, and hereby invites investors, analysts, employees, and other stakeholders to a live ...

Eidesvik Offshore ASA will release its Q2 2025 report on 27 August 2025. The report will be available at www.eidesvik.no and www.newsweb.no. A presentation of the results will be held on 27 August ...

Oslo, Norway, August 20, 2025 – Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, today announced it ...